Paragon Bioservices, the leading private equity-backed biologics contract development and manufacturing organization with proven expertise in gene therapy and next-generation vaccines, is expanding a new process development and cGMP manufacturing facility located conveniently near Baltimore/Washington International Thurgood Marshall (BWI) Airport in Baltimore, Maryland.